Amarin Technologies

Amarin Technologies’ principal activity is the development, licensing and manufacturing of Transdermal Delivery Systems and semisolid formulations for well-known APIs, offering improved formulations of established drugs or generic versions of commercialized products. Since the day it was founded, Amarin has always benefited from a strong R&D culture. It still operates with cutting-edge technology through its formulation and analytical laboratories, which work following cGMP and cGLP guidelines. With its state-of-the-art manufacturing facility, Amarin is the unique company in Latin America whose prescriptive patches are being sold in the main pharmaceuticals markets of the world. On the marketing aspect, we have a strategic association with Helm AG, located in Hamburg, Germany since 2010.